Heart failure (HF) mortality rates in the Texas panhandle are significantly increased compared with the state average rate, ...

Fatphobia—also known as weight discrimination and bias—can appear in healthcare settings with negative impact on a patient's ...

Topline data were announced from a phase 3 trial evaluating baxdrostat in patients with treatment-resistant hypertension.

Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road to acceptance.

Guidelines regarding the management of cardiovascular disease in pregnant patients have been published by the European Society of Cardiology.

An updated report on statistics regarding heart failure epidemiology and outcomes has been published by the HFSA.

People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems.

Prevention strategies for cardiovascular manifestations of acute and long COVID are discussed in a report published online.

Topline data were announced from a phase 3 trial evaluating evolocumab in adults at high cardiovascular risk without prior heart attack or stroke.

Oral semaglutide (25 mg) is effective for weight loss in adults with overweight or obesity without diabetes, according to a study.

Increased hypoxic burden was associated with major cardiovascular and cerebrovascular adverse events (MACCE) in patients with OSA.

Study findings support intensive blood pressure control in patients with hypertension without chronic kidney disease at baseline.